A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease
fluticasone furoate/vilanterol
Pulmonary Disease, Chronic Obstructive
Phase 3
Please note that there is a Publication Steering Committee for this study.
June 2016